Meyka Pro banner
Claritev Corporation

Claritev Corporation Fundamental Analysis (NYSE: CTEV)

CTEV●NYSE
HealthcareMedical - Healthcare Information Services
$28.21
$0.46(1.60%)
U.S. Market opens in 3h 57m

Claritev Corporation Fundamental Analysis (NYSE: CTEV)

Claritev Corporation (NYSE: CTEV) shows moderate financial fundamentals with a PE ratio of -1.73, profit margin of -27.05%, and ROE of 1.04%. The company generates $1.0B in annual revenue with moderate year-over-year growth of 3.74%.

Key Strengths

PEG Ratio-0.07

Areas of Concern

ROE1.04%
Operating Margin5.85%
Cash Position2.12%
We analyze CTEV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 160.5/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
160.5/100

We analyze CTEV's fundamental strength across five key dimensions:

Efficiency Score

Weak

CTEV struggles to generate sufficient returns from assets.

ROA > 10%
-5.88%

Valuation Score

Excellent

CTEV trades at attractive valuation levels.

PE < 25
-1.73
PEG Ratio < 2
-0.07

Growth Score

Moderate

CTEV shows steady but slowing expansion.

Revenue Growth > 5%
3.74%
EPS Growth > 10%
83.03%

Financial Health Score

Excellent

CTEV maintains a strong and stable balance sheet.

Debt/Equity < 1
-13.37
Current Ratio > 1
1.15

Profitability Score

Weak

CTEV struggles to sustain strong margins.

ROE > 15%
104.20%
Net Margin ≥ 15%
-27.05%
Positive Free Cash Flow
No

Key Financial Metrics

Is CTEV Expensive or Cheap?

P/E Ratio

CTEV trades at -1.73 times earnings. This suggests potential undervaluation.

-1.73

PEG Ratio

When adjusting for growth, CTEV's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Claritev Corporation at -1.39 times its book value. This may indicate undervaluation.

-1.39

EV/EBITDA

Enterprise value stands at -8.48 times EBITDA. This is generally considered low.

-8.48

How Well Does CTEV Make Money?

Net Profit Margin

For every $100 in sales, Claritev Corporation keeps $-27.05 as profit after all expenses.

-27.05%

Operating Margin

Core operations generate 5.85 in profit for every $100 in revenue, before interest and taxes.

5.85%

ROE

Management delivers $1.04 in profit for every $100 of shareholder equity.

1.04%

ROA

Claritev Corporation generates $-5.88 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.88%

Following the Money - Real Cash Generation

Operating Cash Flow

Claritev Corporation produces operating cash flow of $131.10M, showing steady but balanced cash generation.

$131.10M

Free Cash Flow

Claritev Corporation generates weak or negative free cash flow of $-27.77M, restricting financial flexibility.

$-27.77M

FCF Per Share

Each share generates $-1.64 in free cash annually.

$-1.64

FCF Yield

CTEV converts -5.80% of its market value into free cash.

-5.80%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.47

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-13.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.04

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How CTEV Stacks Against Its Sector Peers

MetricCTEV ValueSector AveragePerformance
P/E Ratio-1.7331.66 Better (Cheaper)
ROE104.20%501.00% Weak
Net Margin-27.05%-3647.00% (disorted) Weak
Debt/Equity-13.37-0.30 (disorted) Distorted
Current Ratio1.155.78 Neutral
ROA-5.88%-262.00% (disorted) Weak

CTEV outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Claritev Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-26.27%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

60.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-77.74%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ